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Objective: False tendons in the left ventricle are commonly observed. Preliminary observations associate false
tendons with less functional mitral regurgitation.
Methods: Echocardiograms demonstrating severe cardiomyopathy (ejection fraction 30%) were retrospec-
tively examined for left ventricular false tendons. The ejection fraction, cause of left ventricular systolic
dysfunction, left ventricular diastolic dimensions, severity of mitral regurgitation, mitral annular diameter, mitral
valve coaptation depth, mitral valve coaptation area, and orientation of false tendon were evaluated. The patients
with false tendons were compared with a control group with cardiomyopathy without false tendons.
Results: A cohort of patients (n ¼ 82) with severe left ventricular systolic dysfunction (mean ejection fraction,
21%) and false tendons were compared with a control group with similar left ventricular dysfunction and no false
tendons (n ¼ 121; mean ejection fraction, 20%; P ¼ .10). The patients with false tendons had similar left ven-
tricular diastolic internal dimensions compared with the control group (5.99 and 6.18 cm, respectively; P¼ .086).
Yet patients with false tendons had a very low incidence of severe functional mitral regurgitation compared with
the control group (4.9% vs 27%, P< .001). Patients with false tendons had significantly smaller mitral annular
diameters (3.57 vs 4.03 cm, P< .001), shorter mitral valve coaptation depths (0.89 vs 1.24 cm, P< .001), and
reduced coaptation areas (1.61 vs 2.52 cm2, P<.001) than the control group. The reduction of mitral regurgitation
was more significant for patient with transverse midcavity false tendons.
Conclusions: Patients with false tendons and cardiomyopathy have less severe mitral regurgitation. The
mechanism for the reduction in functional mitral regurgitation might be less mitral valve deformation, specifically
lower coaptation depth and coaptation area when a false tendon is present.Functional mitral regurgitation (MR) is mitral valve insuffi-
ciency in the absence of primarymitral valve disease but rather
caused by myocardial dysfunction. Functional MR worsens
prognosis in both ischemic and nonischemic cardiomyopa-
thies.1-3 Themechanisms leading toMRdespite normal leaflet
structure stem from a vicious cycle of left ventricular (LV)
dysfunction, LV sphericity, mitral annular dilation (Carpent-
ier’s type I MR), papillary muscle displacement (Carpentier’s
type IIIb MR), and further LV dilation.4-9 The current treat-
ment of functional MR includes mitral valve replacement or
repair, edge-to-edge mitral leaflet approximation (Alfieri
stitch), mitral annular reinforcement, papillary muscle reposi-
tioning, and emerging percutaneous devices.4,10-12
False tendons in the left ventricle are commonly observed
during routine 2-dimensional echocardiographic analysis.
False tendons (otherwise called false chords or bands) are
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LV cavity with no connection to the valve leaflets.13 The
incidence of false tendons ranges from 18% to 26% during
2-dimensional echocardiographic analysis to a reported
34% incidence at autopsy.13-15 Histologically, false tendons
are highly vascularized and are comprised of fibrous tissue,
myocardial cells, or conductive Purkinje cells.13,14,16 False
tendons have been associated with male sex, premature ven-
tricular contractions, and possibly idiopathic ventricular
tachycardia, but no data are available defining their hemo-
dynamic characteristics.15,17,18
The concept for this study began with the observation that
patients with severely hypokinetic ventricles and LV false
tendons in the midcavity zone appeared to have improved
clinical outcomes.19 Furthermore, it was hypothesized that
by structurally supporting a failing hypokinetic left ventri-
cle, a false tendon might prevent or diminish functional
MR. The purpose of this study was to analyze the effect of
false tendons on LV hemodynamics, specifically MR, in
patients with severe cardiomyopathy.
MATERIALS AND METHODS
Study Cohort
The echocardiogram database from a tertiary-care medical center in Mi-
ami, Florida, was retrospectively searched from April 2003 to August 2006
with the terms ‘‘false tendon,’’ ‘‘false chord,’’ and ‘‘left ventricular band’’rdiovascular Surgery c Volume 138, Number 5 1123




CA ¼ coaptation area
CD ¼ coaptation depth
EF ¼ ejection fraction
LV ¼ left ventricular
MD ¼ mitral annular diameter
MR ¼ mitral regurgitation
for all transthoracic echocardiograms matching these terms. A subset of
these echocardiograms with false tendons and cardiomyopathy with severe
LV dysfunction (ejection fraction [EF], 30%) were isolated, and these
echocardiograms were reviewed to confirm the presence of a false tendon.
The orientation of the false tendon was noted and classified as (1) transverse
midcavity if the chord attached the papillary muscles or opposing LV walls
in the mid third of the LV cavity and (2) apical if at least 1 attachment point
of the chord was in the apical portion of the LV cavity.
Control Group
Sequential patients from the same time period as the false tendon group
with the echocardiographic descriptor severe LV dysfunction and EFs of
less than 30% were used as a control group for comparison. These echocar-
diograms were reviewed to confirm the absence of a false tendon.
The echocardiograms and patients’ charts for both the study cohort and
control group were reviewed for age, sex, EF, cause of LV systolic dysfunc-
tion (ischemic vs nonischemic cardiomyopathy), LV end-diastolic internal
dimension in parasternal long-axis view, LV posterior wall diastolic dimen-
sion, and interventricular septum diastolic dimension. The most recent elec-
trocardiogram at the time of the index echocardiogram was reviewed, and
the underlying ventricular rhythm, any conduction delay, and QRS duration
were noted and recorded. Patients with a history of mitral valve surgery,
mitral valve endocarditis, mitral valve prolapse, rheumatic disease, severe
mitral annular calcification, or images technically inadequate for false ten-
don or MR grading were excluded from the analysis. Although few patients
had significant aortic valvular disease, it was not a prespecified exclusion
criteria. All studies were recorded and analyzed on Philips SONOS 5500
with Xcelera 1.2 software (Philips Medical Systems, Bothell, Wash) or
GE Vivid 7 with EchoPAC PC 4.0.03 software (General Electric Healthcare
Co, Chalford St Giles, United Kingdom).
MR Quantification
MR was graded as none, mild, moderate, or severe by an independent
and separate echocardiographer, and the grading of MR was not adjusted
by the study personnel to eliminate any possible bias. MR was assessed
in multiple views in all patients and was graded according to standard echo-
cardiographic criteria. If no regurgitation jet was seen based on Doppler
color flow in multiple views, the MR was graded as none. MR was graded
as mild if visually the Doppler color jet filled less than 20% of the left atrial
cavity. The grading was defined as moderate if visually the Doppler color
regurgitation jet filled 20% or more of the left atrial cavity. MR was defined
as severe only if there was at least a moderate Doppler color regurgitation jet
with either systolic flow reversal in the pulmonary veins or if the proximal
isovelocity surface area method resulted in an effective orifice area of at
least 0.4 cm2.
Mitral Valve Anatomy
All patients’ echocardiograms were examined for the mitral annular di-
ameter (MD) and mitral valve coaptation depth (CD) in the midsystole api-
cal 4-chamber view (Figure 1). TheMDwas defined as the distance between
the hinge points of the anterior and posterior mitral valve leaflets. The CD1124 The Journal of Thoracic and Cardiovascular Sumeasures the length from the mitral annular plane to the point at which the
mitral leaflets touch during systole. These parameters were used to calculate
the coaptation area (CA; CA¼ 0.53MD3CD). CA is a measure of mitral
valve deformation.
Statistical Analysis
All continuous variables were expressed as the mean  standard devia-
tion. Patient sex, cause of cardiomyopathy, percentage of moderate-to-se-
vere MR, and percentage of severe MR were expressed as descriptive
variables. the Student’s t test and z test for population proportions were
used to compare the continuous and descriptive variables, respectively,
and c2 analysis was used to compare the cause of cardiomyopathy in the
false tendon group versus that seen in the control group.
RESULTS
Echocardiographic database review found396patientswith
false tendons. A subset of 82 patients with severe LV dysfunc-
tion (EF, 30%) was isolated, and their echocardiographic
characteristics and causes of cardiomyopathy were recorded
(Table 1). The orientations of the false tendons in these 82 pa-
tients were as follows: transverse midcavity, 56 patients; api-
cal, 26 patients. The control group consisted of 121 patients
with severeLVdysfunction (EF,30%) andno false tendons,
which was confirmed by means of re-evaluation of the echo-
cardiograms. The echocardiographic parameters and clinical
data for the control group were also recorded (Table 1). There
was no statistical difference in the mean EF between the false
tendon group and the control group (mean EF, 21%  6.4%
vs 20%  5.2%; P ¼ .10), and the median EF was 20% in
both groups. The cause of cardiomyopathy did not differ sig-
nificantly between the false tendon cohort and the control
group, although there was a trend toward more nonischemic
cardiomyopathies in the false tendon cohort (Table 1).
FIGURE 1. Measurement of mitral annular diameter and mitral valve co-
aptation depth was done in the 4-chamber apical views during midsystole.
A, Mitral annular diameter was defined as the distance between the hinge
points of the anterior and posterior mitral valve leaflets. B, Coaptation depth
was measured as the length from the mitral annular plane to the point at
which the mitral leaflets touch during systole.rgery c November 2009
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DTABLE 1. Characteristics of 82 patients with false tendons and EFs of 30% or less compared with control subjects with EFs of 30% or less and no
false tendon
False tendon group Control group P value
No. of subjects 82 121 –
Age (y) 57  14 58  12 .311
Male sex (%) 80 72 .102
Mean EF (%) 21.4  6 20.4  5 .103
Median EF (%) 20 20 –
Left ventricular internal dimension, diastole (cm) 6.0  0.9 6.2  1.1 .086
Interventricular septal dimension, diastole (cm) 1.0  0.2 0.9  0.2 .115
Left ventricular posterior wall dimension, diastole (cm) 0.9  0.2 1.0  0.2 .217
Cause of cardiomyopathy (%)
Ischemic 38 49 .1622
Nonischemic 61 50 .1803
Unknown 1 1 .7808
Mitral regurgitation (% moderate to severe) 33 60 .001
Mitral regurgitation(% severe) 4.9 27 .001
QRS duration (ms) 110  30 107  29 .59
Mitral annular diameter (cm) 3.6  0.7 4.0  0.5 .001
Coaptation depth (cm) 0.90  0.3 1.2  0.3 .001
Coaptation area (cm2) 1.6  0.6 2.5  0.7 .001
EF, Ejection fraction.LV Dimensions
The patients with false tendons had similar LV diastolic
internal dimensions compared with those seen in the con-
trol group (5.99 and 6.18 cm, P ¼ .086), although there
was a trend toward less LV dilation in patients with false
tendons (Table 1).
Mitral Regurgitation
Patients with false tendons had lower proportions of at
least moderate MR than the control group without false
tendons (33% vs 60%, P< .001, Table 1). Furthermore,
there was also a very low incidence of severe MR in pa-
tients with false tendons and severe cardiomyopathy com-
pared with that seen in the control group (4.9% vs 27%,
P< .001, Figures 2 and 3). Subgroup analysis by cause of
cardiomyopathy showed that regardless of the cause, the
incidence of moderate-to-severe MR was statistically less
in patients with false tendons in contrast to control subjects
for ischemic (29% vs 54%, P ¼ .011) and nonischemic
(34% vs 67%, P< .001) cardiomyopathy.
Mitral Valve Anatomy
Patients with false tendons had significantly smaller MDs
(3.57 vs 4.03 cm, P< .001) and shorter mitral valve CDs
(0.89 vs 1.24 cm, P< .001) than seen in the control group
(Table 1). The mitral valves were less deformed in the false
tendon group, with a calculated CA of 1.61  0.64 versus
2.52  0.72 cm2 in the control group (P< .001).
False Tendon Orientation
False tendons with a midcavity transverse orientation had
statistically shorter CDs (P ¼ .01) and smaller CAs (P ¼The Journal of Thoracic and Ca.005), as well as statistically lower rates of severe MR (P
< .001), than apical false tendons (Table 2). The prevention
of at least moderate MRwas limited to patients with midcav-
ity transverse false tendons (P<.001) and not to apical false
tendons (P ¼ .27) when either orientation was compared
with results seen in control subjects.
Electrocardiographic Measure of LV Synchrony
After excluding patients with a paced ventricular rhythm,
the QRS duration between the study cohort and the control
group did not differ significantly (110  30 vs 107  29
ms, respectively; P ¼ .59).
DISCUSSION
To date, there are no published data on the effect of false
tendons on MR. This study suggests that LV false tendons
affect the severity of functional MR in patients with severe
cardiomyopathy and severely reduced LV systolic function,
regardless ofwhether the cause is ischemic or nonischemic in
nature, by influencing the subvalvular apparatus. Further
analysis showed that midcavity false tendons had less mitral
valve deformation and reducedMR than apical false tendons.
The mechanisms of functional MR are complex. Recent
data incorporating quantitative MR determination, cardiac
magnetic resonance imaging, 3-dimensional echocardio-
graphic analysis, and animal models of cardiomyopathy
have uniformly shown that the presence and degree of func-
tional MR is unrelated to the severity of LV dysfunction in
both ischemic and nonischemic cardiomyopathy.4,6,7,20
Rather, the pathophysiology of functional MR is related to
the subvalvular apparatus. Prior studies of the relationship
of mitral annular dilation have shown that although therdiovascular Surgery c Volume 138, Number 5 1125
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DFIGURE 2. Panel A shows the 4-chamber apical echocardiogram of a 46-year-old hypertensive man with nonischemic cardiomyopathy and a left ventricular
ejection fraction of 20%, demonstrating a large transverse midcavity false tendon from the septum to the lateral wall (arrow). The mitral annular diameter and
coaptation depth were measured at 3.8 cm and 0.9 cm, respectively. Panel B shows a Doppler echocardiogram across the mitral valve demonstrating only mild
mitral insufficiency. In contrast, panel C demonstrates the apical 4-chamber echocardiographic view for a 61-year-old woman with type 2 diabetes and is-
chemic cardiomyopathy with a dilated left ventricle measured at 8 cm, an estimated left ventricular ejection fraction of 20%, and no false tendon with a mea-
sured mitral annular diameter and coaptation depth of 4.5 cm and 1.8 cm, respectively. Panel D shows severe mitral regurgitation by means of Doppler
echocardiographic analysis, with evidence of pulmonary vein reversal and a regurgitant jet filling more than 20% of the left atrium.mitral valve annulus dilates symmetrically in both ischemic
and nonischemic cardiomyopathies, MD does not correlate
with MR severity or cause of cardiomyopathy.8,9,21 CD
and CA are emerging diagnostic and prognostic parameters
linking functionalMR tomitral subvalvular deformation and
leaflet tenting.5,6,22 Mechanistically, dysfunctional myocar-
dium displaces papillary muscles that tether and pull the mi-
tral leaflets toward the apex during systole. This apical
displacement of the mitral leaflets leads to increased CD
and CA with incomplete leaflet coaptation and thus func-
tional MR.4,6 CD and CA are parameters that can be incor-
porated into routine 2-dimensional echocardiographic
examination. CD and CA have been shown to be increased
in patients with cardiomyopathy, and CD and CA correlate
proportionally to quantitatively determined mitral effective
regurgitant orifice area.6 There are conflicting data as to
the mechanisms of functional MR in ischemic versus noni-
schemic cardiomyopathies. Recent data concluded that CD
was a major determinant of the degree of MR in only ische-
mic cardiomyopathy, whereas previously, a similar correla-
tion between the mitral tenting area and MR in all types of
cardiomyopathy was reported.5,6 CD and CA also contribute
prognostic data; a CD of greater than 1.1 cm and a CA of
greater than 1.7 cm2 have been shown to be predictors of
failure of mitral valve surgical repair or replacement.23,24
Our current results demonstrated a significantly decreased
amount of MR in patients with cardiomyopathy and false1126 The Journal of Thoracic and Cardiovascular Sutendons. The observed association between false tendons
and less functional MR might have various explanations.
False tendons are histologically comprised of fibrous tissue,
myocardial cells, and/or conductive Purkinje cells,13,14,16
and therefore they might provide some degree of tethering
support to the left ventricle, an alternate conductive circuit,
or some combination of both. It is unclear by which mecha-
nism the false tendons might act to reduce the degree of
mitral insufficiency.
If significant electrical conduction is present through the
conductive tissue within the false tendons, then they could
hypothetically serve to make LV depolarization more ho-
mogenous and overall improve LV synchrony. Cardiac re-
synchronization reduces MR by improving LV mechanical
synchrony, which leads to an increase in LV longitudinal
function and a reduction in subvalvular traction and less api-
cal displacement of coaptation.25 Although an imperfect
measure, QRS duration is a rough estimate of ventricular
synchrony26 and has been used as a criterion for evaluating
patients for resynchronization therapy with biventricular
pacing therapy.27 In our study the QRS duration in the study
cohort did not differ significantly from that seen in the con-
trol group, suggesting that improved LV synchrony might
not be a causative factor in the diminished MR observed
in patients with false tendons. Unfortunately, given that
this was a retrospective study, we were unable to evaluate
echocardiographic measures of dysynchrony. However, itrgery c November 2009
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sess the role, if any, that false tendons might have on echo-
cardiographic markers of LV synchrony.
An alternative explanation is that a reinforcing false ten-
don serves a role to buttress the failing, dilated left ventricle.
Although the trend for less LV dilation in patients with false
tendons was not significant in our study, the false tendons
might have a role at the subvalvular level to improve overall
LV geometry. By limiting papillary muscle displacement,
despite severe LV dysfunction, false tendons might result
in less apical tenting of the mitral leaflets in systole. This
can be directly assessed by measuring CD and CA. In this
study patients with false tendons had decreased CDs and
CAs compared with those seen in control subjects. A trans-
verse midcavity orientation of false tendon had distinctly
lower rates of MR with less mitral valve deformation (lower
CD and CA) than seen in either control or apically oriented
false tendons. In fact, the subgroup of patient with apical
false tendons did not have significantly different rates of
moderate-to-severe MR compared with that seen in control
subjects (54% vs 60%, P ¼ .27). Patients with transverse
midcavity–positioned false tendons had preserved subvalv-
ular geometry (CD and CA) and statistically less functional
MR than either control or apically oriented false tendons.
Perhaps midcavity transverse false tendons are mechanically
aligned to absorb LV distorting forces and counteract
FIGURE 3. Incidence of severe mitral regurgitation (MR) according to the
presence or absence of a false tendon and the cause of cardiomyopathy.
Overall, patientswith false tendons and a cardiomyopathy had a significantly
lower percentage of severe mitral regurgitation compared with control sub-
jects. EF, Ejection fraction.The Journal of Thoracic and Capapillary muscle displacement, thus possible explaining
less functional MR in this subgroup. Additionally, because
of a false tendon, there is less negative global remodeling
of the dysfunctional ventricle, as witnessed by a significantly
smaller MD and a nonsignificant trend toward decreased
LV diastolic internal dimension. These data analyzing false
tendons and MR are unique in that no previous study has
studied false tendons as a natural structural tether in cardio-
myopathy or the interaction of false tendons with subvalvu-
lar mechanisms. In fact, no positive hemodynamic attribute
has ever been associated with false tendons.
The reduction of functional MR was apparent and statisti-
cally significant in both ischemic and nonischemic cardiomy-
opathies. Therefore because there is a similar hemodynamic
benefit of false tendons, common mechanisms leading to
functionalMRmight be present in ischemic and nonischemic
cardiomyopathies.
The conclusions of our data have some similarities to
some emerging treatments of functional MR. Various surgi-
cal and percutaneous therapies that target the mitral valve
leaflets are currently under development. In addition,
some therapies are emerging that target the left ventricle
or subvalvular apparatus with the hopes of improving LV
remodeling. A surgically implanted subvalvular strut that
is tightened across the ventricle with the purpose of reposi-
tioning the papillary muscles and reducing functional MR
is under development.28 Recent experiments in both a ca-
nine cardiomyopathy model and 1-year follow-up of 11 hu-
man subjects with the subvalvular strut implanted at the
time of coronary artery bypass grafting showed improve-
ments in functional MR caused by a reduction in MD
and papillary muscle repositioning.28-30 The data from
these trials with surgically implanted struts is congruent
with our current findings in which LV false tendons also re-
duce functional MR, possibly by preserving subvalvular
anatomy. Further research needs to elucidate this mecha-
nism more clearly, but it might suggest that future therapies
that target the subvalvular apparatus and decrease CA and






No. of subjects 56 26 –
Age (y) 57  13 57  16 .47
Male sex (%) 80 81 .48
EF (%) 21.7  6 21.0  7 .32
Mitral regurgitation
(% moderate to severe)
23 54 .003
Mitral regurgitation (% severe) 1.8 12 .001
QRS duration (ms) 120  35 106  28 .08
Mitral annular diameter (cm) 3.6  0.6 3.6  0.8 .39
Coaptation depth (cm) 0.8  0.2 1.0  0.3 .01
Coaptation area (cm2) 1.5  0.5 1.9  0.8 .0049
EF, Ejection fraction.rdiovascular Surgery c Volume 138, Number 5 1127
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tional MR.
Limitations
This study has several limitations. Patients with false
tendons were identified retrospectively from an echocardio-
graphic database. Therefore some eligible patients with false
tendons might not have been identified or included in the
study. There was no assessment of the timing of the echocar-
diogram, including investigation of medications, volume
status, time period of cardiomyopathy, or patient condition,
that could affect MR across the false tendon and control
groups. In addition, the echocardiographic quantification
of MR, although based on standard criteria as described,
was not reassessed and was dependent on the initial echocar-
diographic interpretation. Although limitations are present
in this retrospective analysis, these limitations would be ex-
pected to affect the false tendon and control group equally.
Although it might be interesting for future investigation,
we did not collect any prospective follow-up data as to the
clinical significance of the decrease in functional MR in pa-
tients with false tendons. Overall, the association between
false tendons and decreased functional MR was strong.
CONCLUSION
Patients with false tendons and severe LV dysfunction
have tethering effects yielding positive hemodynamic
characteristics, specifically less severe MR. The mechanism
for the reduction in functional MR might be a reduction in
papillary muscle separation and mitral valve deformation
measured by the reduced CD and CA when a false tendon
is present. The benefit of false tendons is most apparent
when aligned in the transverse midcavity orientation.
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